The positive Q1 earnings report from Travere Therapeutics is directly responsible for the increase in its stock price. Earnings reports are critical indicators of a company's financial health and can significantly impact investor sentiment and stock prices. The positive earnings suggest that the company is performing well, which typically leads to increased investor confidence and higher stock prices in the short term.